Remove Healthcare Remove Manufacturing Remove Pharmaceutical
article thumbnail

Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?

Mad in America

What’s concerning is that despite the significant impact of sexual dysfunction on patients’ quality of life, many did not discuss these issues with their healthcare providers. Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine.

article thumbnail

A Simple Workaround to Overcome the Bureaucratic Mindset

Tanveer Naseer

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop. So sue me” was the response.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. They are not medical diseases.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

In 2000, JAMA reported the US yearly estimated iatrogenic deaths: 12,000 caused by unnecessary surgeries; 27,000 caused by medication errors and other errors in hospitals; 80,000 hospital/healthcare facility acquired infections; and 106,000 “non-error” adverse effects of medication. and the number of early-onset cancer deaths increased by 27.7%

Reporting 142
article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

Moynihan’s research and writing focus on the healthcare industry, with an emphasis on how diseases are created, branded, and marketed to unsuspecting people. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. I started writing books.

article thumbnail

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

With the explosion of more and more drugs in cabinets across the country, more and more children are dying—but still, pharmaceutical companies push their products, leading to yet more drugs and yet more deaths. Unlike the pharmaceutical industry, in our village community the pain of losing a single child was felt by all.

article thumbnail

MindFreedom’s Shield Program: Working to Free People from Psychiatric Incarceration and Forced Treatment

Mad in America

Somatics LLC marked a watershed moment for advocates who have fought for decades for ECT device manufacturer accountability. The Himes decision “clarifies a gap in the law that the pharmaceutical industry has exploited for decades,” said plaintiff’s attorneys Wisner Baum in a statement.